Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Commercial Services

Transcrip offers experts to augment in-house drug development

By Gareth Macdonald, 09-Sep-2009

Related topics: Globalisation, Commercial Services, PodCast news direct, Phase I-II, Phase III-IV, Preclinical, Regulatory affairs

Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite.

Loading...

Interview with Paul Branthwaite
Senior partner, TranScrip Partners

The international partnership consists of almost 20 pharma industry experts and academics who work with clients’ in-house drug development teams on a contractual basis.

As Branthwaite explained Transcrip aims to “provide knowledge and operational capability in drug development in its widest context, working across multiple therapeutic and ‘functional’ areas.”

Already substantial by consulting group standards in the pharma space, it offers a flexible resourcing model that allows clients to access Partners’ capabilities to fill skill, experience and/or resource gaps, by integrating with and augmenting client teams.”

Almac sees growing demand for non-GMP contracting

Almac sees growing demand for non-GMP contracting

David Downey

VP Commercial Operations, Almac Pharma Services

The right questions key to assessing CRO performance, says study team

The right questions key to assessing CRO performance, says study team

Dr Michael Howley

Associate Clinical Professor , LeBow College of Business, Drexel University

CROs' complex demands are changing the tissue supply biz, says industry expert

CROs' complex demands are changing the tissue supply biz, says industry expert

Vadim Alexandre

equity analyst, Daniel Stewart & Company

Patient Recruitment Outsourcing in emerging markets: the good, the bad, and the ugly

Shaylyn Pike

Head of emerging markets research team, Cutting Edge Information

Patient recruitment must evolve, says Cutting Edge Information

Patient recruitment must evolve, says Cutting Edge Information

Eric Bolesh

Director of research, Cutting Edge Information

Patient recruitment best outsourced, says market analyst

Patient recruitment best outsourced, says market analyst

Eric Bolesh

Director of research, Cutting Edge Information

Realistic, evidence-based patient recruitment goals are key, Shire

Joseph Kim

Director of Clinical Operations, Shire Pharmaceuticals

Firecrest's site performance software goes mobile

Firecrest's site performance software goes mobile

Nigel Hughes

Head of Business Development, Firecrest Clinical

Parexel CEO reflects on Pfizer deal

Parexel CEO reflects on Pfizer deal

Joseph von Rickenbach

Chairman, CEO, Parexel

Biopharm waste material mix a chance to cut landfill costs

Biopharm waste material mix a chance to cut landfill costs

Lucy Russell

security shredding manager , Smurfit Kappa Recycling

‘Guinea piggers’ at large in the pharmaceutical industry

‘Guinea piggers’ at large in the pharmaceutical industry

Kerri Weingard

Research Director, Accumed

Industry, innovation & Viagra-stuffed teddies at AAPS

Industry, innovation & Viagra-stuffed teddies at AAPS

Last week everything from co-processed excipients to Viagra-stuffed teddies were discussed at AAPS 2010....

Global reach key for CDMOs, says Recipharm CEO

Global reach key for CDMOs, says Recipharm CEO

Thomas Eldered

CEO, Recipharm

REMS a cross departmental challenge for drugmakers says PPD

REMS a cross departmental challenge for drugmakers says PPD

Frank Gallo

executive director of risk manatgement, PPD

Biopharma needs value focused commercial model, says Quintiles

Biopharma needs value focused commercial model, says Quintiles

Jim Featherstone

vice president, consulting group, Quintiles

eClinical talks future of data management

eClinical talks future of data management

Susan Bornstein

Executive Vice President, eClinical Solutions

Patient recruiters & regulators educating each other as trials globalise

Patient recruiters & regulators educating each other as trials globalise

Jeffrey Zucker

Senior director and global head of patient recruitment, Kendle

KCAS talks biomarker strategy development

KCAS talks biomarker strategy development

Proveen Dass

Associate Director of ligand binding assay services, KCAS

Parexel discusses transdermal drug delivery techs

Parexel discusses transdermal drug delivery techs

Ravi Harapanhalli

Principal Consultant and Practice Lead for Late Stage Product Development...

Quotient says screening of prototype formulations is crucial to drug delivery

Quotient says screening of prototype formulations is crucial to drug delivery

Peter Schole

VP, pharmaceutical sciences, Quotient Clinical

Covance adding mass spec for biosimilars

Covance adding mass spec for biosimilars

Ray Kaiser

Chief Scientific Officer, Biotechnology, Covance

Patheon mulls drug delivery tech deals to accelerate development services growth

Patheon mulls drug delivery tech deals to accelerate development services growth

Mark Kontny

President, Global Pharmaceutical Development Services, Patheon

Catalent eyes acquisitions in emerging market and drug delivery expansion

Catalent eyes acquisitions in emerging market and drug delivery expansion

Scott Houlton

President, Development and Clinical Services, Catalent

Icon sets its sights on genomics development

Icon sets its sights on genomics development

Brian O’Dwyer

senior VP for global bioanalytical services, Icon

Norwich amps up its pilot scale production capabilities at NY plant

Norwich amps up its pilot scale production capabilities at NY plant

Terry Novak

President, Norwich Pharmaceuticals

Rapid recruitment in emerging regions can overload sites; FDA

Rapid recruitment in emerging regions can overload sites; FDA

Cynthia Kleppinger

Medical Officer, Division of Scientific Investigations, CDER, FDA

Sponsors and CROs both have key role in quality; FDA

Sponsors and CROs both have key role in quality; FDA

Ann Meeker O’Connell

Acting Associate Director of Risk Science, Intelligence & Prioritization, FDA

ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011

ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011

The Big Pharma CRO strategic partnering model, its impact on drug development and the...

OSP meets Pfizer's REMOTE virtual trial partners at DIA 2011

OSP meets Pfizer's REMOTE virtual trial partners at DIA 2011

In June global drug giant Pfizer began what it described as the world’s first...

Quintiles talks about challenges of data management in today’s trials sector

Quintiles talks about challenges of data management in today’s trials sector

Paula Brown Stafford

President, Clinical Development, Quintiles

Fiscal benefits of drugs a priority for cash-strapped countries

Fiscal benefits of drugs a priority for cash-strapped countries

Geoff Fatzinger

director of regulatory affairs and strategic product development, INC Research

Strategic relationships are changing Pharma and CRO skillset says Parexel

Strategic relationships are changing Pharma and CRO skillset says Parexel

Joshua Schultz

corporate VP of strategic account leadership, Parexel

Synteract talks rescue studies at DIA 2011

Synteract talks rescue studies at DIA 2011

Stewart Bieler

COO, Synteract

Theorem CR talks about life after spin out at DIA 2011

Theorem CR talks about life after spin out at DIA 2011

James Pusey

CEO, Theorem Clinical Research

Parexel talks global trial regulations at DIA 2011

Parexel talks global trial regulations at DIA 2011

Alberto Grignolo

Corporate Vice President, Global Strategy and Services, Parexel International

Chiltern says strategic deals are good for the CRO sector

Chiltern says strategic deals are good for the CRO sector

Aize Smink

Senior Executive VP, Global Clinical Development, Chiltern

Quintiles launches silo busting data management platform at DIA

Quintiles launches silo busting data management platform at DIA

Thomas Grundstrom

VP of global data solutions, Quintiles

Celerion talks about research sector in South America

Celerion talks about research sector in South America

US CRO Celerion gained Brazilian National Health Surveillance Agency (Agência Nacional de Vigilancia Sanitaria...

PRA reflects on data and information management at DIA

PRA reflects on data and information management at DIA

Steve Powell

Senior VP of clinical informatics and late phase services ,...

DSA talks social media in pharma at DIA 2011

DSA talks social media in pharma at DIA 2011

Elizabeth Garrard

Chief Safety Officer, DSA

Medidata to add SaaS CTMS through Clinical Force buy

Medidata to add SaaS CTMS through Clinical Force buy

Graham Bunn

Vice president of partnerships and alliances, Medidata

Almac talks expansion at Interphex 2011

Almac talks expansion at Interphex 2011

James McGibbon

direstor of business development, pharma services, Almac

EDT talks about the contract manufacturing market at Interphex

EDT talks about the contract manufacturing market at Interphex

Philip Pratten

Vice president, manufacturing services operations, Elan Drug Technologies

Patheon talks about backup manufacturing service at Interphex 2011

Patheon talks about backup manufacturing service at Interphex 2011

Geoffrey Glass

Executive VP of Global Strategy, sales and marketing, Patheon

Interest in functional service model on the rise; Chiltern

Interest in functional service model on the rise; Chiltern

Pat Ling

director of global key accounts , Chiltern

Follow us on